Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p. Issue 17 (1st September 2020)

• Record Type: Journal Article
• Authors: Ma, Minglei; Ma, Chifa; Li, Pingping; Ma, Chunxiao; Ping, Fan; Li, Wei; Xu, Lingling; Zhang, Huabing; Sun, Qi; Li, Yuxiu
• Is Part Of: Cell cycle. Volume 19:Issue 17(2020)
• Page Start: 2168
• Page End: 2181
• Publication Date: 2020-09-01
• Subjects: Pancreatic cancer -- metformin -- glucose -- miR-210-5p -- PFKFB2 -- glycolysis -- energy stress; Cell cycle -- Periodicals; 571.84377
• DOI: 10.1080/15384101.2020.1796036
• Languages: English
• ISSNs: 1538-4101

Abstract

ABSTRACT: To explore mechanisms underlying the discrepancy in anti-tumor effects of metformin on pancreatic cancer cells PANC-1 under different glucose conditions. We cultured PANC-1 cells in 25 mM and 5 mM glucose media, then treated with or without metformin. It showed that metformin significantly inhibited proliferation and viability, induced apoptosis of PANC-1 cells, which was more pronounced in low-glucose than in high-glucose group. Metformin up-regulated the expression of miR-210-5p in low glucose, but not in high glucose. miR-210-5p mimic inhibited the viability of PANC-1 cells and further enhanced the inhibitory effect of metformin. miR-210-5p down-regulated the expression of PFKFB2, a predicted target gene of miR-210-5p, reduced the activity of PFK1 and LDH. Metformin significantly inhibited the expression of phosphorylation-PFKFB2(p-PFKFB2) in the low-glucose group and inhibited the LDH activity both in the low and high glucose groups, thus inhibiting anaerobic glycolysis and inducing energy stress. Cells in the high glucose group could make a compensatory adaptation to the energy stress induced by metformin through increasing glucose consumption. However, due to the limited glucose supply and high dependence on anaerobic glycolysis of cells in the low glucose group, they couldn't make effective adaptive compensation. Therefore, cells in the low-glucose group were more vulnerable to the toxicity of metformin. In conclusion, the enhanced inhibitory effect of metformin on PANC-1 cells cultured in low glucose may be due to the up-regulation of the expression of miR-210-5p, then inhibiting anaerobic glycolytic flux and inducing energy stress via repressing the expression of p-PFKFB2 and activity of LDH. Abbreviations: PC: pancreatic cancer; DM: diabetes mellitus; PFKFB2: 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase2; PFK1: phosphofructokinases; LDH: lactate dehydrogenase; F-2, 6-BP: fructose 2, 6-bisphosphate